Apexigen, Inc.
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development f…
Biotechnology
US, San Carlos [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Apexigen, Inc. has no acquisition track records yet.
M&A Deals · History
Apexigen, Inc. has no acquisition track records yet.